Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis

Mark Sculpher

首页> 外文期刊>Rheumatology >Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis

【24h】

Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis

机译：模拟银屑病关节炎生物治疗的成本效益

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives. A probabilistic model was developed to determine the cost-effectiveness of three biologics, etanercept, infliximab and adalimumab, compared with palliative care for the treatment of active and progressive PsA in patients who have an inadequate response to standard treatment (including DMARDs).

机译：目标。与概率疗法相比，开发了一种概率模型来确定依那西普，英夫利昔单抗和阿达木单抗这三种生物制剂与积极治疗和进行性PsA的姑息治疗相比，这些患者对标准治疗反应不佳（包括DMARD）。

著录项

来源
《Rheumatology》 |2011年第4期|p.39-47|共9页
作者
Mark Sculpher;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. [J] . Bojke L, Epstein D, Craig D, Rheumatology . 2011,第Suppla4期

机译：模拟银屑病关节炎的生物治疗的成本效益。
2. Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective [J] . Timo Purmonen, Kari Puolakka, Devarshi Bhattacharyya, Cost Effectiveness Resource Allocation . 2018,第1期

机译：Secukinumab与其他生物学和Apremilast治疗活性银屑病关节炎的成本效果分析：芬兰视角
3. Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries? [J] . Patton Thomas, Bojke Laura, Walton Matthew, Clinical rheumatology . 2017,第8期

机译：评估银屑病关节炎生物治疗的成本效益：我们可以更好地利用患者数据注册机构吗？
4. Active Latent Space Shape Model: A Bayesian Treatment of Shape Model Adaptation with an Application to Psoriatic Arthritis Radiographs [C] . Adwaye Rambojun, William Tillett, Tony Shardlow, IEEE Winter Conference on Applications of Computer Vision . 2021

机译：主动潜空间形状模型：一种贝叶斯造型模型适应与应用于银屑病关节炎
5. Appraisal of models for the study of disease progression in psoriatic arthritis [D] . Aguirre-Hernandez, Rebeca. 2000

机译：对银屑病关节炎疾病进展研究模型的评估
6. Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK [O] . Bernd Schweikert, Chiara Malmberg, Örjan Åkerborg, 2020

机译：综合中高于对严重牛皮癣治疗活性银屑病性关节炎肝素与Secukinumab的顺序生物治疗成本效果分析
7. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis [O] . L. Bojke, D. Epstein, D. Craig, 2011

机译：模拟银屑病关节炎生物处理的成本效益

Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis

摘要

著录项

相似文献

相关主题

期刊订阅